United Health Products, Inc.
UEEC
$0.17
-$0.01-5.56%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -0.82% | -8.32% | -62.95% | -14.68% | -4.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.01% | -14.78% | -59.67% | -19.31% | -21.88% |
| Operating Income | 13.01% | 14.78% | 59.67% | 19.31% | 16.45% |
| Income Before Tax | 37.47% | 17.38% | 60.45% | 29.02% | -159.19% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 37.47% | 17.38% | 60.45% | 29.02% | -159.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 37.47% | 17.38% | 60.45% | 29.02% | -159.19% |
| EBIT | 13.01% | 14.78% | 59.67% | 19.31% | 16.45% |
| EBITDA | 13.02% | 14.80% | 59.72% | 19.36% | 16.50% |
| EPS Basic | 40.00% | 22.73% | 63.27% | 34.48% | -155.56% |
| Normalized Basic EPS | 15.38% | 15.38% | 62.07% | 53.85% | -156.52% |
| EPS Diluted | 40.00% | 22.73% | 63.27% | 34.48% | -168.97% |
| Normalized Diluted EPS | 15.38% | 15.38% | 62.07% | 53.85% | -168.42% |
| Average Basic Shares Outstanding | 2.95% | 3.97% | 5.34% | 5.77% | 4.79% |
| Average Diluted Shares Outstanding | 2.95% | 3.97% | 5.34% | 5.77% | -13.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
